The cohort of 700 patients with uterine cancer performed by Engerud et al. [38] showed PD-L1 and PD-1 expression in 59 and 63% in primary tumors, respectively, with similar expression patterns across microsatellite stable (MSS) and MSI tumors. This evidence concerns the gene CD274 and uterine cancer.